MARTELL RON
President and CEO
MARTELL RON has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2025.
On the most recent filing, MARTELL RON is listed as President and CEO at Jasper Therapeutics, Inc. Inside the rolling window, MARTELL RON reported 1 open-market purchase totaling $100K in JSPR and no open-market sales.
Companies traded
Other insiders at JSPR
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MARTELL RON made?
MARTELL RON has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does MARTELL RON trade?
MARTELL RON has filed SEC Form 4 disclosures for 1 company, including JSPR.
When was MARTELL RON's most recent SEC Form 4 filing?
MARTELL RON's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2025.
What is MARTELL RON's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, MARTELL RON is listed as President and CEO.
What is MARTELL RON's total buy and sell value in the current window?
Inside the rolling retention window, MARTELL RON bought $100K and sold $0 based on SEC Form 4 filings.
What was MARTELL RON's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 41,000 JSPR shares on 2025-09-22, worth $100K, per SEC Form 4 filings.